Integra Lifesciences Holdings (IART) Misses Q1 EPS by 1c

Integra Lifesciences Holdings (NASDAQ: IART) reported Q1 EPS of $0.57, $0.01 worse than the analyst estimate of $0.58. Revenue for the quarter came in at $215.1 million versus the consensus estimate of $213.3 million.

For earnings history and earnings-related data on Integra Lifesciences Holdings (IART) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• STEALTHGAS INC. Announces the Date for the Release of the Second Quarter 2026 Financial and Operating Results, Conference Call and Webcast
• BofA sees mixed signals for European software from US SaaS